Return to homepagePandemic Pact

COVIRIC: Durability of protective immune responses triggered by primary SARS-CoV-2 infection in patients with rheumatoid arthritis or spondyloarthritis - Impact of immunosuppressive treatments.

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $0

  • Funder

    ANR

  • Principal Investigator

    Corinne Miceli

  • Research Location

    France

  • Lead Research Institution

    Hôpitaux de Paris Groupe Hospitalier Cochin Saint-Vincent-de-Paul / Paris

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The COVIRIC project, coordinated by Corinne Miceli (Assistance Publique - Hôpitaux de Paris Groupe Hospitalier Cochin Saint-Vincent-de-Paul / Paris), aims to study the impact of immunosuppressive treatments on viral load and humoral and cellular responses during a viral infection with SARS-CoV-2, in patients with rheumatoid arthritis or spondyloarthritis, compared to other members of the infected family group.